Green Street believes that WP Carey's recent multimillion dollar sale-leaseback transaction with a leading generic drug manufacturer in Canada "could suggest increased demand for sale-leaseback financing following the recent banking crisis in early March that likely tightened bank lending standards for small and medium-sized businesses."
Net Lease REIT W.P. Carey in April executed the largest transaction in the company's 50-year history with a $468 million sale-leaseback of a portfolio of four pharmaceutical R&D and manufacturing campuses in the Greater Toronto Area.
The portfolio represents the lion's share of the global operations of Apotex Pharmaceutical Holdings, the largest generic drug manufacturer in Canada.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
